Literature DB >> 23252726

Screening for diabetic retinopathy in pregnancy using photographic review clinics.

R Hampshire1, H Wharton, R Leigh, A Wright, P Dodson.   

Abstract

AIMS: To assess the efficacy and value of the National Institute for Health and Clinical Excellence guidelines for digital photographic screening for diabetic retinopathy in pregnancy using photographic review clinics.
METHODS: Pregnant patients (n = 186) with known diabetes were screened at first antenatal visit and at 28 weeks' gestation, if no retinopathy was noted at first visit, or at other intervals if retinopathy was present. Two 45° images (disc-centred and macula-centred views) were taken in both eyes and graded by trained graders and by an ophthalmologist.
RESULTS: Ninety-three patients (50%) remained free of diabetic retinopathy throughout pregnancy. Eighteen (10%) presented with sight-threatening retinopathy at their first antenatal screen and were referred to the hospital eye service. Fifty patients (27%) were shown to have relatively stable retinopathy throughout pregnancy, with only two patients deteriorating and requiring referral to hospital eye service. Twenty-three (12%) failed to complete the screening protocol after their first screen.
CONCLUSIONS: The study showed that pregnant patients screened for retinopathy in an ophthalmic photographic diabetic review clinic achieved National Institute for Health and Clinical Excellence guidelines in the majority and were clinically safe. Only 1% of patients required referral to ophthalmology after their initial screen, thus avoiding unnecessary hospital eye service appointments.
© 2012 Crown copyright. Diabetic Medicine © 2012 Diabetes UK.

Entities:  

Mesh:

Year:  2013        PMID: 23252726     DOI: 10.1111/dme.12077

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Global Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Women With Preexisting Diabetes: A Systematic Review and Meta-analysis.

Authors:  Felicia Widyaputri; Sophie L Rogers; Rathika Kandasamy; Alexis Shub; Robert C A Symons; Lyndell L Lim
Journal:  JAMA Ophthalmol       Date:  2022-05-01       Impact factor: 8.253

Review 2.  Intravitreal anti-vascular endothelial growth factor medications during pregnancy: current perspective.

Authors:  Morteza Naderan; Masomeh Sabzevary; Keivan Rezaii; Ali Banafshehafshan; Seddigheh Hantoushzadeh
Journal:  Int Ophthalmol       Date:  2020-10-12       Impact factor: 2.031

Review 3.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

4.  Diabetic retinopathy in pregnancy: a population-based study of women with pregestational diabetes.

Authors:  Aoife M Egan; Lyle McVicker; Adrienne Heerey; Louise Carmody; Fiona Harney; Fidelma P Dunne
Journal:  J Diabetes Res       Date:  2015-04-06       Impact factor: 4.011

5.  Nonmydriatic Photographic Screening for Diabetic Retinopathy in Pregnant Patients with Pre-Existing Diabetes in a Safety Net Population: 1 Year Results from the Diabetic Retinopathy in Pregnant Patients Study.

Authors:  Malini Veerappan Pasricha; Jodi So; David Myung; Andrea Jelks; Carolyn K Pan
Journal:  Womens Health Rep (New Rochelle)       Date:  2020-09-28

6.  Prevalence, progression, and outcomes of diabetic retinopathy during pregnancy in Indian scenario.

Authors:  Tarjani Makwana; Brijesh Takkar; Pradeep Venkatesh; Jai Bhagwan Sharma; Yashdeep Gupta; Rohan Chawla; Rajpal Vohra; Alka Kriplani; Nikhil Tandon
Journal:  Indian J Ophthalmol       Date:  2018-04       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.